1. Home
  2. NOVT vs STVN Comparison

NOVT vs STVN Comparison

Compare NOVT & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novanta Inc.

NOVT

Novanta Inc.

HOLD

Current Price

$140.94

Market Cap

5.0B

Sector

Miscellaneous

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.58

Market Cap

5.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOVT
STVN
Founded
1968
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Containers/Packaging
Sector
Miscellaneous
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.2B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
NOVT
STVN
Price
$140.94
$19.58
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
★ $194.50
$24.47
AVG Volume (30 Days)
★ 345.8K
315.7K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 0.32%
EPS Growth
N/A
★ N/A
EPS
★ 0.82
N/A
Revenue
★ $521,290,000.00
N/A
Revenue This Year
$15.57
$6.96
Revenue Next Year
$15.87
$9.15
P/E Ratio
$166.59
★ $27.15
Revenue Growth
★ 35.49
N/A
52 Week Low
$98.27
$12.89
52 Week High
$176.38
$27.00

Technical Indicators

Market Signals
Indicator
NOVT
STVN
Relative Strength Index (RSI) 50.01 45.30
Support Level $133.50 $18.75
Resistance Level $144.65 $20.02
Average True Range (ATR) 6.60 0.64
MACD -0.14 0.03
Stochastic Oscillator 47.29 44.59

Price Performance

Historical Comparison
NOVT
STVN

About NOVT Novanta Inc.

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: